 All subjects randomized to receive α-CD will orally ingest two tablets containing α-CD, or placebo, with a standardized liquid breakfast 100 μ Ci of 3Htriolein and 20 μ Ci of 14C tripalmitin. The tablets will be consumed with 150 ml of still uncarbonated water immediately prior to consuming each meal. 